Accendra Health shareholders approve amended equity incentive plan at annual meeting

Filed May 15, 2026 · Period ending May 14, 2026 · ~1 min read

Key Changes

• medium

  Shareholders approved the Amended and Restated 2023 Omnibus Incentive Plan with 97% support, allowing the Board's People & Culture Committee to grant stock awards to employees, directors, and consultants.

  Item 5.02 verify on EDGAR →
• low

  All six director nominees elected for one-year terms with 93-98% approval; Edward Pesicka received lowest support at 93% while other directors received 97-98%.

  Item 5.07 verify on EDGAR →
• low

  Say-on-pay vote passed with 92% support, indicating general shareholder approval of executive compensation though support was lower than other proposals.

  Item 5.07 verify on EDGAR →